Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy--Are We There Yet?
Cancer J 2015 Jul-Aug;21(4):337-42.
PMID: 26222087
Radiolabeled temozolomide can measure bevacizumab induced vascular modulation in patients with recurrent GBM.
Proc Annual Meeting Society for Neuro-Oncology, 2015.
Perfusion MRI: A potential biomarker of tumor response in clinical trials
Proc American Association for Cancer Research conference on Tumor Angiogenesis and Vascular Normalization: Bench to Bedside to Biomarkers, 2015
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport